Abstract
Meningococcal disease is among the most feared infections of children and young adults because of the rapidity of onset, high mortality rate, devastating sequelae, and tendency to spread and cause outbreaks. Two articles in this issue of THE JOURNAL1,2 highlight the challenge of serogroup B meningococci—the most common cause of meningococcal disease in many countries.

This publication has 1 reference indexed in Scilit: